2m 2m 2m 2m 2m 2m 2m
Liquidia (LQDA)
NASDAQ
$66.67-$0.07 (-0.10%)
Price as of Sep 11, 2026 7:40 PM EDT- $6.0BMarket Cap
- 156.79%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Liquidia (LQDA)
$66.67-$0.07 (-0.10%)
LQDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $66.74 | ||
Change | -$1.11 (-1.64%) | ||
Open | $68.66 | ||
High | $69.94 | ||
Low | $66.68 | ||
Previous Close | $67.85 | ||
Volume | 778,798 | ||
30-Day Average Volume | 1,474,402 | ||
1-Week Change | -2.80% | ||
1-Month Change | -24.20% | ||
1-Year Change | 156.79% | ||
3-Year Change | 845.33% | ||
5-Year Change | 2,353.68% | ||
Fundamentals | |||
Shares Outstanding | 89.5M | ||
Total Assets | $521.9M | ||
Market Cap | $6.0B | ||
Enterprise Value | $5.7B | ||
Period: QTR TTM FY | |||
Revenue | $170.4M | ||
Net Income | $74.7M | ||
Free Cash Flow | $69.0M | ||
EBIT | $81.7M | ||
EBITDA | $82.1M | ||
Net Working Capital | $248.4M | ||
EPS | $0.74 | ||
Enterprise Value/EBITDA | 69 | ||
Enterprise Value/Revenue | 33 | ||
P/B | 31 | ||
P/E | 90 | ||
PEG | 2 | ||
Price/Free Cash Flow | 87 | ||
Price/Operating Cash Flow | 74 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue